In a lawsuit filed Thursday in Manhattan federal court, Northwest Biotherapeutics alleged Citadel Securities, Susquehanna International Group, Virtu Americas, Canaccord Genuity and other Wall Street market makers repeatedly engaged in "spoofing," where traders place orders with an intent to fool other investors and manipulate the share price, Justin Baer of Wall Street Journal reports. Reference Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on NWBO: